Anti-GPC6A/ GPRC6A/ GPCR monoclonal antibody

Anti-GPC6A/ GPRC6A/ GPCR antibody for FACS & in-vivo assay

Target products collectionGo to GPRC6A/GPRC6A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T72032-Ab-1/ GM-Tg-hg-T72032-Ab-2Anti-Human GPRC6A monoclonal antibodyHuman
GM-Tg-rg-T72032-Ab-1/ GM-Tg-rg-T72032-Ab-2Anti-Rat GPRC6A monoclonal antibodyRat
GM-Tg-mg-T72032-Ab-1/ GM-Tg-mg-T72032-Ab-2Anti-Mouse GPRC6A monoclonal antibodyMouse
GM-Tg-cynog-T72032-Ab-1/ GM-Tg-cynog-T72032-Ab-2Anti-Cynomolgus/ Rhesus macaque GPRC6A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T72032-Ab-1/ GM-Tg-felg-T72032-Ab-2Anti-Feline GPRC6A monoclonal antibodyFeline
GM-Tg-cang-T72032-Ab-1/ GM-Tg-cang-T72032-Ab-2Anti-Canine GPRC6A monoclonal antibodyCanine
GM-Tg-bovg-T72032-Ab-1/ GM-Tg-bovg-T72032-Ab-2Anti-Bovine GPRC6A monoclonal antibodyBovine
GM-Tg-equg-T72032-Ab-1/ GM-Tg-equg-T72032-Ab-2Anti-Equine GPRC6A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T72032-Ab-1/ GM-Tg-hg-T72032-Ab-2; GM-Tg-rg-T72032-Ab-1/ GM-Tg-rg-T72032-Ab-2;
GM-Tg-mg-T72032-Ab-1/ GM-Tg-mg-T72032-Ab-2; GM-Tg-cynog-T72032-Ab-1/ GM-Tg-cynog-T72032-Ab-2;
GM-Tg-felg-T72032-Ab-1/ GM-Tg-felg-T72032-Ab-2; GM-Tg-cang-T72032-Ab-1/ GM-Tg-cang-T72032-Ab-2;
GM-Tg-bovg-T72032-Ab-1/ GM-Tg-bovg-T72032-Ab-2; GM-Tg-equg-T72032-Ab-1/ GM-Tg-equg-T72032-Ab-2
Products NameAnti-GPRC6A monoclonal antibody
Formatmab
Target NameGPRC6A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GPRC6A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GPC6A/ GPRC6A/ GPCR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000022human GPRC6A Lentivirus particle
    ORF Viral VectorpGMLV000022human GPRC6A Lentivirus plasmid
    ORF Viral VectorpGMLPm004488mouse Gprc6a Lentivirus plasmid
    ORF Viral VectorvGMLPm004488mouse Gprc6a Lentivirus particle


    Target information

    Target IDGM-T72032
    Target NameGPRC6A
    Gene ID222545,210198,294394,715520,484095,101092611,783669,100067090
    Gene Symbol and SynonymsbA86F4.3,GPCR,GPRC6A
    Uniprot AccessionQ5T6X5,Q70VB1,E1BPQ3
    Uniprot Entry NameGPC6A_HUMAN,GPC6A_RAT,GPC6A_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000173612
    Target ClassificationTumor-associated antigen (TAA)

    The target: GPRC6A, gene name: GPRC6A, also named as GPCR, bA86F4.3. 0.



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.